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Background: Proper functional association between mural cells and endothelial cells (EC) causes EC of blood
vessels to become quiescent. Mural cells on tumor vessels exhibit decreased attachment to EC, which allows vessels
to be unstable and proliferative. The mechanisms by which tumors prevent proper association between mural
cells and EC are not well understood. Since gap junctions (GJ) play an important role in cell-cell contact and
communication, we investigated whether loss of GJ plays a role in tumor-induced mural cell dissociation.
Methods: Mural cell regulation of endothelial proliferation was assessed by direct co-culture assays of fluorescently
labeled cells quantified by flow cytometry or plate reader. Gap junction function was assessed by parachute assay.
Connexin 43 (Cx43) protein in mural cells exposed to conditioned media from cancer cells was assessed by Western
and confocal microscopy; mRNA levels were assessed by quantitative real-time PCR. Expression vectors or siRNA
were utilized to overexpress or knock down Cx43. Tumor growth and angiogenesis was assessed in mouse hosts
deficient for Cx43.
Results: Using parachute dye transfer assay, we demonstrate that media conditioned by MDA-MB-231 breast cancer
cells diminishes GJ communication between mural cells (vascular smooth muscle cells, vSMC) and EC. Both protein
and mRNA of the GJ component Connexin 43 (Cx43) are downregulated in mural cells by tumor-conditioned
media; media from non-tumorigenic MCF10A cells had no effect. Loss of GJ communication by Cx43 siRNA
knockdown, treatment with blocking peptide, or exposure to tumor-conditioned media diminishes the ability of
mural cells to inhibit EC proliferation in co-culture assays, while overexpression of Cx43 in vSMC restores GJ and
endothelial inhibition. Breast tumor cells implanted into mice heterozygous for Cx43 show no changes in tumor
growth, but exhibit significantly increased tumor vascularization determined by CD31 staining, along with decreased
mural cell support detected by NG2 staining.
Conclusions: Our data indicate that i) functional Cx43 is required for mural cell-induced endothelial quiescence,
and ii) downregulation of Cx43 GJ by tumors frees endothelium to respond to angiogenic cues. These data define
a novel and important role for maintained Cx43 function in regulation of vessel quiescence, and suggest its loss
may contribute to pathological tumor angiogenesis.
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A functional blood vessel is composed of the endothelium,
the cell layer that forms the channel through which blood
flows, and mural cells, the vascular smooth muscle cells
(vSMC) and pericytes that serve to support and stabilize
the endothelium. Proper physical and functional associ-
ation between mural cells and endothelial cells (EC)
causes EC to become quiescent [1]. In addition, mural
cells contribute to vessel stability via regulation of de-
position of basement membrane proteins and enhance-
ment of tight junctions between endothelial cells [2, 3].
In contrast, the vasculature formed by a tumor is highly
disorganized and exhibits decreased and abnormal asso-
ciation with mural cells [4, 5], which allows the vessel to
be unstable, leaky and proliferative. However, the molecu-
lar determinants that mediate the inhibitory interactions
between mural cells and endothelial cells, and the mecha-
nism(s) by which tumors prevent proper association be-
tween mural cells and the endothelium, have not been
well elucidated. Knowledge of the mechanism(s) by which
mural cells dissociate from vessels would significantly
increase the understanding of physiological blood vessel
development, as well as pathological conditions such as
tumor angiogenesis in which these basic processes appear
to be deregulated.
Gap junctions (GJ) are membrane channels that allow
the transfer of ions, second messengers, and other small
molecules between adjacent cells [6]. GJ are composed
of connexin proteins, of which the product of the GJA1
gene, Connexin 43, is a main component in the vas-
culature. Functional heterologous gap junctions have
been described between EC and mural cells [7–9]. In-
deed, Cx43-based gap junctions have been shown to
be required for the endothelial-induced differentiation
of mural cell precursors during vessel assembly [9]. In
addition, these gap junctions play a role in integrating
vasopressive signals along the vessel to maintain vascular
tone [10] and are required for proper coronary vessel
patterning [11, 12]. In this study, we have explored
the role of Cx43 in the inhibitory interactions be-
tween mural cells and endothelial cells and the alter-
ation of Cx43 expression and function in a model of
tumor angiogenesis. We find that Cx43-based gap junc-
tion activity is required for the mural cell-induced
endothelial quiescence that is characteristic of stabi-
lized vessels, and that breast tumor cell downregulation
of mural cell Cx43 is sufficient to release endothelial
cells from this inhibition to allow endothelial prolifera-
tion. Further, we show that tumor angiogenesis is in-
creased in a Cx43-deficient host. These data therefore
provide a possible mechanistic explanation for the mat-
uration defect characteristic of vasculature in tumors
and other angiogenic pathologies which allows vessels
to be proliferative.Methods
Cell culture and reagents
MDA-MB-231 human breast cancer cells were obtained
from the Georgetown University Repository and main-
tained in IMEM, 10 % FBS. STR analysis (CellCheck,
RADIL, University of Missouri) confirmed origin of these
cells as MDA-MB-231. Conditioned media (CM) was pre-
pared by incubating a 90 % confluent monolayer of MDA-
MB-231 cells in EBM-2 (Lonza, Walkersville, MD) for
24 h. Human MCF10A and MCF7 from the WFU Tissue
Virus and Vector Core were maintained in RPMI-1640 +
10 % FBS. To screen for relative potency of conditioned
media, flasks of ~90 % confluent cells were incubated with
EBM-2 for 24 h. In some experiments, cells from the
conditioning flasks were then trypsinized and counted,
and all media equalized to the same cell number/ml
media. vSMC (primary human coronary artery smooth
muscle cells, passage 5 to 8, Lonza [5 lots] or Cascade
Biosciences, Eugene, OR [1 lot]) and HBVP (human
brain vascular pericytes, passage 4–8, ScienCell, Carls-
bad, CA) were maintained in SmGM-2 (Lonza). HUVEC
(passage 5 to 9, Lonza), GFP-HUVEC (passage 4 to 6,
Angio-Proteomie, Boston, MA), and GFP-HBMEC (hu-
man brain microvascular pericytes, passage 4–7, Angio-
Proteomie) were maintained in complete EGM2-MV
(Lonza). C3H10T1/2 (passage 12 to 14) and MDA-MB-
468 cells were purchased from ATCC (Manassas, VA)
and maintained in low glucose DMEM (Hyclone, South
Logan, UT), 10%FBS. Eo771 mouse mammary tumor
cells (kind gift of Dr. Francis Sirotnak, Memorial Sloan
Kettering Cancer Center) were maintained in RPMI-
1640 + 10 % FBS. All incubations were carried out in a
humidified atmosphere at 37 °C and 5 % CO2.
Measurement of endothelial proliferation in Co-culture
Three co-culture cell models were used: (i) vSMC and
HUVEC: For tumor conditioned media experiments,
GFP-HUVEC (1200–1800 cells/well of 96 well plate) were
co-cultured with vSMC at a ratio of 1:1.5 in EGM2-MV
for 24 h, followed by addition of Mock and MDA-MB-231
CM supplemented with 1 % FBS. GFP fluorescence (Exc
485 nm, Em 520) was measured on a BMG Labtek
Fluorostar Optima plate reader on day 4 as a measure of
HUVEC cell number. GFP-HUVEC and vSMC mono-
cultures plated in Mock and MDA-MB-231 CM were
used as controls. For Cx43 overexpression, vSMC were
nucleofected with control or pCMV6-XL5-Cx43 vector
twenty-four hours prior to plating in co-culture and an-
alyzed as above. For knockdown experiments, PKH26-
labeled vSMC nucleofected with non-targeting siRNA
or siRNA specific for Cx43 were co-cultured with GFP-
HUVEC or in monoculture in 6-well plates. On indi-
cated day, cells were trypsinized and counted on a
hemocytometer followed by FACS analysis to determine
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in the suspension. Total cell counts from hemocytometer
readings and percentage counts from FACS were used to
determine number of HUVEC in the co-culture. Co-
cultures were also set up in the presence of 250 μM Cx43
GAP26 (sequence VCYDKSFPISHVR) or scrambled con-
trol peptide (GenScript, Piscataway, NJ); cultures received
fresh media with GAP26 peptide on the third day of
culture. (ii) HBVP and GFP-HBMEC: GFP-HBMEC
were co-cultured with HBVP at a ratio of 1:1.5 as
above, except that CM was supplemented with 2.5 %
FBS. (iii) C3H10T1/2 and HUVEC: C3H10T1/2 cells
were nucleofected with non-targeting or Cx43-targeted
siRNA, allowed to recover overnight, labeled with Cell-
Tracker Green, then added to PKH-26 labeled HUVEC.
Controls consisted of C3H10T1/2 and HUVEC cul-
tured alone in identical conditions. On indicated day,
cells were trypsinized and quantified by FACS as above,
except that red fluorescence indicated HUVEC and green
indicated C3H10T1/2.Western blot analysis
vSMC were starved 16–18 h in basal EBM-2, 0.1 % BSA
then stimulated with Mock or MDA-MB-231 CM for
24 h and lysed in RIPA buffer (1 % NP-40, 0.5 % Sodium
Deoxycholate, 1 % SDS) containing 1X Thermo Scien-
tific Halt Phosphatase Inhibitor Cocktail and Roche
Complete Mini Protease Inhibitor. Protein content was
quantified and equal quantity of protein separated by SDS-
polyacrylamide gel electrophoresis and transferred onto
nitrocellulose membrane (Thermo Scientific, Waltham,
MA). After blocking, the membrane was probed with
antibodies specific for Cx37 (Abcam), Cx40 (Millipore),
Cx43 (Cell Signaling, Danvers, MA), Cx45 (Sigma) and
loading control (Tubulin, Labvision, Fremont, CA; β-Actin,
Sigma; or GAPDH, Cell Signaling), followed by exposure
to appropriate horseradish-peroxidase-linked secondary
antibody (Amersham Life Sciences, Piscataway, NJ). Bound
antibody was detected using chemiluminescence (ECL
Plus, Amersham) and quantified using ImageJ software
(NIH) or Scion Image software. Data were normalized
to loading control and expressed as relative Cx43 levels
compared to corresponding mock.Nucleofection
vSMC or C3H10T1/2 cells at 80 % confluence were
trypsinized and nucleofected with control non-targeting
siRNA or the appropriate (human or mouse) siRNA pool
directed against Cx43 (Dharmacon, Lafayette, Colorado),
or pCMV6-XL5-Cx43 or control vector (Origene,
Rockville, MD), using an Amaxa NucleofectorII and
Primary Smooth Muscle kit solution (Lonza) per manu-
facturer’s directions.Parachute assay
GJ activity was measured by a noninvasive parachute assay
as described [13] using vSMC as “donor” cells and HUVEC
as “acceptor” cells. HUVEC acceptor cells were labeled
with the nontransferable dye PKH-26 (Sigma-Aldrich, St
Louis, MO) using the manufacturer’s protocol, washed
with PBS, resuspended in fresh media and 5 × 105 cells
plated in 6-cm dishes. vSMC donor cells were loaded with
0.1 μΜ calcein-AM (Sigma-Aldrich) in growth medium
with 2.5 mM probenecid (Biomol, Plymouth Meeting, PA)
for 30 min at 37 °C. After loading, donor cells were tryp-
sinized and 105 cells dropped onto PKH-26-labeled ac-
ceptor cells and incubated at 37 °C for 3 h. For Mock
and MDA-MB-231 CM groups, vSMC were treated for
24 h prior to calcein-AM loading. For Cx43 alterations,
vSMC were nucleofected with siRNA or plasmid twenty-
four hours prior to calcein-AM loading. The GJ communi-
cation inhibitor 18-α-Glycyrrhetinic acid (MP Biomedical,
Irwine, CA) was used as negative control. To assess degree
of dye coupling, cells were harvested in single cell suspen-
sions by trypsin digestion, and fluorescence detected on a
FACS Calibur flow cytometer (BD Biosciences, San Jose,
CA) using a 488 nm filter for calcein and a 585 nm filter
for PKH-26. GJ intercellular (GJIC) communication
transfer ratio was calculated using the formula: (Num-
ber of acceptor cells X Fraction of double-labeled cells)/
Number of donor cells. Data are presented as Relative
Transfer Ratio, which was calculated by normalizing
values to Control Mock.Confocal imaging
GFP-HUVEC (10,000-15,000 cells/well) were co-cultured
with vSMC at a ratio of 1:1.5 in EGM2-MV for 24 h, then
media replaced with EBM-2 + 1 % FBS for 48 h. Cells were
then stimulated with Mock or MDA-MB-231 CM treat-
ment for 24 h. For immunolabeling, fixed cells were
probed with mouse monoclonal anti-Cx43IF1 antibody
(Fred Hutchison Cancer Research Center, Seattle, WA)
followed by anti-mouse secondary antibody conjugated
to Alexa Fluor 555 (Cell Signaling). Fluorescently la-
beled cells were imaged on a Zeiss LSM 510 Axiovert
100 M confocal microscope (Carl Zeiss MicroImaging
Inc, Thornwood, NY) using a Exc 488 nm/Em 505
(GFP-HUVEC) and Ex543/Em650 (Alexa Fluor 555) at
x200 with additional digital magnification up to x440.
The 8-bit images were obtained in a 512 x 512 pixel for-
mat with 6–11 optical slices of 1.7 μm thickness each.
vSMC-GFP-HUVEC cell pairs were marked and the cross-
section of the z-stack was scanned across the X-Y plane
using the orthogonal function of the LSM Image Examiner
(Carl Zeiss Microimaging Inc.). Cx43 staining extending
beyond margin of GFP-HUVEC was counted as hetero-
typic gap junction.
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Total RNA was extracted using TRIzol® and DNase
digested using RT2 qPCR grade RNA Isolation kit (SA
Biosciences, Frederick, MD). Synthesis of cDNA was car-
ried out using SABiosciences RT2 First Strand Kit with
400–800 ng total sample RNA. PCR was performed using
an ABI-PRISM 7000 Detection System thermal cycler
(Applied Biosystems, Carlsbad, CA) in a 25 μl reaction
consisting of SA Biosciences RT2 qPCR Master Mix/ROS,
1 μl human GJA1 or GAPDH primers (Real Time Primers,
Elkins Park, PA) primers, and 1 μl of template cDNA
using the cycling conditions: 10 min at 95 °C (1 cycle):
95 °C 15 s, 60 °C for 1 min (45 cycles). Data were normal-
ized to GAPDH and fold-change for 231 CM-treated rela-
tive to mock calculated using the ΔΔCt method [14].
Mouse generation and tumor implantation
All experiments were approved by the Wake Forest
School of Medicine Institutional Animal Care and Use
Committee. Mice heterozygous for the Cx43 gene were
generated by crossing mice with the second exon of
Cx43 flanked by loxP sites (Jackson Laboratories, strain
#008039, [15]) with mice in which CRE is expressed ubi-
quitously under control of the CMV promoter (Jackson
Laboratories, strain #006054), both of which were gen-
erated on a C57Bl/6 background. Related mice homozy-
gous for the floxed Cx43 gene (which express normal
levels of Cx43) were used as wild-type controls. Western
analysis of mammary fat pads without tumor implantation
confirmed reduction of Cx43 protein in the Cx43 Het
mice to 47.3+/−10.7 % that of control mice (n = 8).
Eo771 mouse medullary adenocarcinoma cells (2.5x105),
derived from a spontaneous mammary tumor in a
C57Bl/6 mouse, were injected into the inguinal mam-
mary fat pad of WT (n = 11) and Cx43 Het mice (n =
10). Tumor size was measured twice a week using a
digital caliper, and tumor volume estimated using the
formula (((L +W)/2)^3)/2 [16]. The experiment was ter-
minated at 14 days post-injection.
Immunofluorescence
Eo771 mammary fat pad tumors were removed and flash
frozen in OCT medium (Tissue-Tek) and cut to 7 μm sec-
tions, allowed to thaw to room temp for 30 min, fixed for
10 min in 100 % acetone and blocked for 1 h in 3 % BSA
in PBS. Sections were incubated in anti-CD31 (BD Biosci-
ences) and/or anti-NG2 (Millipore) overnight at 4 °C
followed by secondary Alexa 488 or 555 (Cell Signaling)
for 1 h at room temp and mounted with Fluorogel + DAPI
(EMS). Fluorescent microscopy was performed on an
Olympus IX70 scope and images acquired at 20x with a
Retiga 200R camera. The area of CD31 positive fluores-
cent pixels across five random fields was quantified using
Image J software and averaged for each of 8 tumors perexperimental group. To assess vessel mural cell investi-
ture, relative area of CD31 positive vessels were quantified
for area of NG2 positive pixels on 5 random vessels per
tumor, 3 tumors per group and quantified using Image J
software.
Statistical analysis
Statistical analyses were performed in the Biostatistics
Core Facility of the Comprehensive Cancer Center of
Wake Forest University using SAS version 9.2. All data
are presented as means +/− s.e.m. across experiments of
the averages of the replicate values within an experi-
ment. The significance of Cx43 knockdown/inhibition or
tumor CM treatment on dye transfer or endothelial pro-
liferation was determined using a mixed model ANOVA
with linear contrasts to assess specific pairwise compari-
sons between groups of interest. Experimental condi-
tions were assumed to be nested within experiments,
and the Tukey-Kramer method was used to adjust for
multiple contrasts. Tumor growth over time was ana-
lyzed using repeated measures ANOVA with square root
transformed data to improve normality and stabilize var-
iances. Student’s t-test was used to compare gap junction
quantification by microscopy, CD31 area, NG2/CD31 ra-
tio and tumor mass; for CD31 area, data were log trans-
formed to normalize the data. Statistical significance was
set at p < 0.05.
Results
Breast tumor cells release endothelial cells from mural
cell growth inhibition
The ability of mural cells to inhibit the proliferation of
endothelial cells is well established [1, 17, 18]. In order
to study the effects of tumors on mural cell dissociation
at the initiation of angiogenesis, we first tested whether
tumors reverse the inhibitory effects of mural cells in an
in vitro endothelial cell-mural cell co-culture using pri-
mary human vSMC as a mural cell model and GFP-
labeled HUVEC as the endothelial component. As seen
in Fig. 1a, media conditioned by tumor cells had min-
imal effect on the proliferation of endothelial cells cul-
tured alone compared to mock conditioned media after
four days in culture (p = 0.903, ns). Consistent with
previous reports [17], endothelial cell proliferation was
decreased in the presence of vSMC when co-cultured in
control media (decreased 39.6+/−4.9 % from control mono-
culture, p < 0.01). In contrast, when co-cultures were first
allowed to associate overnight then exposed for four days
to media conditioned by MDA-MB-231 breast tumor
cells, the ability of mural cells to inhibit endothelial pro-
liferation was completely reversed. The ability of tumor
conditioned media to override mural cell inhibition of
endothelial proliferation was also observed using a co-
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Fig. 1 Breast tumors release endothelial cells from mural cell
inhibition and downregulate mural cell Cx43. vSMC and GFP-HUVEC
a or HBVP and GFP-HBMEC b were plated alone or in co-culture
overnight in normal growth media, then cultured in control media
(‘Mock’) or media conditioned by MDA-MB-231 cells (‘231’) or MCF10A
cells (‘10A’). At the end of four days, fluorescence was quantified. Data
shown are representative of three experiments performed in duplicate
or triplicate (**p < 0.01; ***p = 0.001). c Western analysis of indicated
endothelial or mural cells starved overnight then stimulated for 24 h
with control media (‘Mock’) or media conditioned by tumor cells (‘231’)
and are representative of at least 2–4 replicate experiments for each
cell line. d Quantification of Cx43 protein levels compared in vSMC
and HBVP treated for 24 h with media conditioned by MDA-MB-231
tumor cells or control mock media normalized to tubulin levels
(n = 6 different vSMC donor lots; *** p < 0.001; for HBVP n = 3
independent experiments with 2 different donor lots; *p < 0.05)
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control monoculture, p = 0.002). In contrast, media con-
ditioned by nontumorigenic MCF10A mammary epithe-
lial cells did not promote endothelial proliferation in
co-culture. The tumor-induced loss of the ability of
mural cells to inhibit endothelial proliferation was un-
likely due to a decrease in mural cell number following
exposure to tumor conditioned media, as tumor condi-
tioned media stimulates proliferation of mural cells
(Additional file 1: Figure S1). This co-culture system
demonstrates tumor-dependent subversion of stabiliz-
ing mural cell-endothelial cell interactions and provides
a means to interrogate the mechanisms by which tu-
mors disrupt inhibitory signals required for this effect.Breast tumor cells downregulate Cx43 protein in mural
cells but not endothelial cells
Since mural cell mediated inhibition of endothelial prolif-
eration is reportedly contact-dependent [17], we analyzed
expression of gap junctional molecules in endothelial cells
and mural cells following exposure to media conditioned
by breast cancer cells. While no consistent decreases in
connexin expression in response to MDA-MB-231 tumor
cell conditioned media was observed in either endothelial
cell line, tumor conditioned media decreased total protein
levels of Cx43 in both mural cell types after 24 h treat-
ment (Fig. 1c). Although a tumor-induced decrease in
Cx37 in vSMC was also detected, previous reports indi-
cate that heterocellular junctions between vascular endo-
thelial cells and mural cells are composed primarily of
mural cell Cx43 [9] and endothelial Cx43/40 [19], with
limited presence of Cx37 at heterocellular junctions in the
microvasculature [19, 20]. We therefore elected to further
pursue the role of Cx43 regulation in mural cells. The
ability of MDA-MB-231 cell conditioned media to de-
crease Cx43 protein levels was consistently observed in
human vSMC isolated from at least 6 out of 7 different
donors and HBVP from at least two different donors, with
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(Fig. 1d) in responding cells, respectively.Breast tumor conditioned media inhibits Cx43-based GJ
Communication between EC and MC
We next addressed whether breast tumor cell-induced
loss of vSMC Cx43 affected heterotypic GJ communica-
tion between vSMC and endothelial cells using a para-
chute dye transfer assay quantified by flow cytometry. In
agreement with previous studies [21], significant dye
transfer was observed between mural cells and endothe-
lial cells (Fig. 2a, b). In contrast, vSMC exposed to breast
tumor conditioned media demonstrated a significant de-
crease (to 22.3+/−5.0 % of control) in capacity to transfer
dye to endothelial cells (Fig. 2b), suggesting that tumor
media prevents the formation of functional heterocellular
gap junctions. Similarly, knock down of Cx43 by siRNA
also nearly completely abolished the transfer of dye from
vSMC to endothelial cells (down to 21.2+/−5.1 % of con-
trol) indicating that Cx43 is the main mural cell connexin
protein mediating GJ communication with endothelial
cells. Lysates from vSMC monocultures plated in parallel
probed for total Cx43 confirm the magnitude of protein
loss in response to the indicated treatment (Fig. 2c). The
chemical GJ inhibitor 18-α-glycyrretinic acid, which does
not affect Cx43 levels, nearly completely abolishes the
transfer (Fig. 2b, c), demonstrating that observed dye
transfer is mediated by GJ. Consistent with this, con-
focal detection of Cx43 gap junctions extending be-
tween mural cells and endothelial cells in co-culture,
which seemed to preferentially form when mural cells
oriented themselves over endothelial cells, was quantifi-
ably decreased following treatment with tumor condi-
tioned media (3.19+/−0.32 mock vs. 1.43+/−0.47 with 231
conditioned media, p = 0.01, Fig. 2d). Together these
data indicate that tumor cells dowregulate the major
mural cell connexin mediating GJ transfer between
mural cells and endothelial cells to disrupt established
heterotypic GJ communication.Regulation of Cx43 by tumor cells
In order to determine whether cells other than MDA-MB-
231 possess the ability to downregulate Cx43 in mural
cells, we screened conditioned media from a panel of hu-
man breast cancer cell lines. Consistent with its inability
to release endothelial cells from mural cell inhibition,
media from immortalized non-tumorigenic mammary epi-
thelial cell line MCF10A did not alter Cx43 levels in
vSMC after 24 h treatment (Fig. 3a). Similarly, media from
less aggressive estrogen receptor positive (ER+) cells such
as MCF7 also did not consistently diminish Cx43 levels,
whereas media from more highly aggressive ER- cells such
as the MDA-MB-468 cells decreased Cx43 protein levelsmore similar to that seen with MDA-MB-231 CM (45 %
and 56 % respectively) (Fig. 3b).
Mechanistically, we determined that the downregula-
tion of Cx43 protein by MDA-MB-231 tumor cells is
time- and dose-dependent (Fig. 3c, d). Although small
changes in Cx43 protein levels may be evident at shorter
time points (2 h, relative Cx43 protein 0.88 compared to
2 h mock, n = 3, p = 0.16, ns; 4-5 h, relative Cx43 protein
0.78, n = 4. p = 0.09, ns), significant decreases in Cx43
protein are not observed until after more prolonged ex-
posure to 231 CM. Quantitative PCR analysis demon-
strates that exposure to 231 CM results in Cx43 mRNA
decrease that is evident within 4 h (down to 56.9+/−5.5 %
control) and continues to decrease through 12 h (down to
28.4+/−4.0 %) compared to mock media, suggesting that
the loss of Cx43 protein is mediated in part by decrease in
mRNA (Fig. 3e).
Functional Cx43-containing GJ are required for mural
cell-induced endothelial growth inhibition
We next addressed the functional significance of Cx43
loss in mediating mural cell-endothelial cell growth inhibi-
tory interactions. Cx43 has been shown to be required for
endothelial cell contact-induced differentiation of mesen-
chymal mural precursor cells [9]. Consistent with previous
reports [17], the proliferation of endothelial cells in co-
culture with C3H10T1/2 mural precursor cells was signifi-
cantly reduced compared to endothelial cells plated alone
(down to 56.5+/−8.3 %, p < 0.05, Fig. 4a); knockdown of
Cx43 in C3H10T1/2 cells by siRNA significantly reverses
this inhibition of endothelial proliferation (Fig. 4b). We
next addressed whether Cx43 expression is similarly re-
quired for the endothelial growth inhibition exerted by
fully differentiated vSMC cells. While differentiated vSMC
exhibit significant growth inhibition on endothelial cells
(63.0+/−14.4 %, p < 0.005, Fig. 4c), siRNA knockdown of
Cx43 similarly attenuates the ability of vSMC to inhibit
endothelial proliferation, indicating a requirement for
mural cell Cx43 in this function. Western blot analysis
shows Cx43 levels were significantly reduced following
siRNA treatment while other connexins remain virtually
unaltered (Fig. 4b, d). These data suggest that the ob-
served requirement for Cx43 in mural cell-mediated
endothelial inhibition is a general phenomenon.
Since Cx43 can reportedly confer anti-proliferative ef-
fects that are independent of its ability to form GJ [22],
we sought to determine whether the observed reversal
of mural cell-mediated endothelial growth inhibition was
dependent on GJ activity. To distinguish this, the co-
culture assay was performed in the presence of the block-
ing peptide Cx43 GAP26 which blocks the formation of
Cx43 gap junction channels between cells (reviewed in
[23]) but does not affect Cx43 protein levels. In the pres-
ence of a scrambled control peptide, vSMC cells retain the





t=0                             siNT                             siCx43




























Fig. 2 Gap junction communication between mural cells and endothelial cells requires mural cell Cx43 and is decreased by tumor cells. Untransfected
vSMC or vSMC nucleofected with non-targeting (‘siNT’) or Connexin43-specific (‘siCx43’) siRNA were treated with control (‘Mock’) or media conditioned
by MDA-MB-231 cells (‘231 CM’), loaded with calcein-AM, and plated onto PKH26-labeled HUVEC. Dye transfer from vSMC to HUVEC was quantified
using flow cytometry. a. Representative flow cytometry dot plots showing dye transfer as percentage of double-labeled cells in upper right quadrant.
b. Ratio of dye transfer as calculated in Materials and Methods. Data represent the mean of four to five independent experiments performed in
triplicate +/−s.e.m. (duplicate for 18-GA); ***p < 0.001. c. Western analysis of Connexin 43 in vSMC samples incubated in parallel with experiment
from A. d. vSMC and GFP-HUVEC were plated in co-culture for 72 h as in ‘Methods’, then stimulated for 24 h with control media (‘Mock’) or
media conditioned by MDA-MB-231 cells (‘231 CM’), and the number of heterocellular Cx43-expressing junctions (red) extending between
endothelial cells (green) and mural cells quantified by confocal Z-stack analysis. Top panel, representative confocal images; inset, magnification
of z-stack image of Cx43 gap junction. Bottom panel, quantification of Cx43-positive heterotypic gap junctions as seen in top panel. Data
represent the quantification from paired cells over three experiments (n = 46–48 cell pairs each condition)+/−s.e.m. (*p < 0.05)
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30+/−4.5 % compared to EC mono, p < 0.05); in contrast,
the Cx43 GAP26 blocking peptide nearly completely re-
versed the ability of vSMC to inhibit endothelial growth
(EC mono 17.7+/−0.3, GAP26 Co 16.3+/− 1.2, ns; Fig. 4e).The Cx43 GAP26 peptide had no significant effect on
proliferation of endothelial cells alone (Additional file 2:
Figure S2). Together these data indicate that mural cell-
mediated endothelial growth inhibition requires gap junc-
tion activity that is dependent on mural cell Cx43.
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Fig. 3 Breast tumor downregulation of Cx43 in vSMC is time- and dose- dependent. a, b. vSMC were stimulated for 24 h with media conditioned
by the indicated cell line and lysates analyzed for Cx43 levels. Bottom panels represent quantification of a n = 4 experiments, b n = 5 experiments,
*p < 0.05; **p < 0.01; ***p < 0.001. c. vSMC were treated for the indicated time with media conditioned by MDA-MB-231 cells and lysates analyzed
by Western. Data representative of two to four experiments. d vSMC were treated for 24 h with media conditioned by varying dilutions of
MDA-MB-231 cell CM. Bottom panel represents quantification from 3 independent experiments. e. mRNA was isolated and subjected to
quantitative PCR analysis. Data were normalized to GAPDH levels and fold change compared to Mock; data represent the mean of three independent
experiments each performed in technical triplicate (*p < 0.05; **p < 0.01)
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cell inhibition is dependent on downregulation of Cx43
In order to determine whether loss of Cx43 alone is
responsible for the release of endothelial inhibition, we
tested whether overexpression of Cx43 was sufficient to
restore mural cell growth inhibition of endothelial cells.
Although ectopic Cx43 expression does not increase
basal GJ dye transfer between mural cells and endothe-
lial cells, mural cells nucleofected with a wild-type Cx43
expression plasmid retain functional gap junctions with
endothelial cells despite the presence of tumor media
(Fig. 5a; Cx43 Mock vs. Cx43 231, p = 0.908, ns). The abil-
ity of tumor cells to prevent mural cell-mediated endothe-
lial growth inhibition in co-culture was reversed when
mural cells maintain expression of Cx43 (Cx43 231 Co vs.231 Vector Co, p = 0.014; Fig. 5b). Together, these data
suggest that tumor-induced loss of heterocellular Cx43
gap junctions promotes endothelial proliferation by releas-
ing endothelial cells from mural cell growth inhibition.
Proliferation of tumor endothelium is increased and
pericyte investiture decreased on a Cx43-reduced host
background
In order to address the in vivo significance of Cx43 loss
on angiogenesis, Eo771 mouse mammary tumor cells
were implanted into the mammary fat pad of female syn-
geneic C57Bl/6 wild-type (WT) mice or mice that were
bred to be heterozygous for Cx43 (Cx43 Het). Excised
tumors from these mice were immunostained for the
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Fig. 4 Mural cell inhibition of endothelial cell proliferation requires mural cell Cx43 and GJ communication. Labeled mural cells (a and b, C3H
10 T1/2 cells, or c and d, vSMC) nucleofected with control non-targeting or Cx43 siRNA were cultured with labeled HUVEC and effects on
HUVEC proliferation assessed by cell counting followed by flow cytometry at indicated days. a. Pooled data from three independent experiments
performed in triplicate using HUVEC from two different donors. (*p < 0.05). b. Western analysis of Cx43 expression from representative experiment
from A. c. Pooled data from five independent experiments performed in triplicate using vSMC from three different donors and HUVEC from two
different donors (*p < 0.05; *** p = 0.001). d. Western analysis of Cx43 expression from representative experiment from C. e. Labeled mural cells
were cultured with GFP-HUVEC for four days in the presence of GAP26 blocking peptide or control scrambled peptide and effects on HUVEC
proliferation assessed as in A. Data shown are from a representative of two experiment performed in triplicate (*p < 0.05)
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endothelial cells in the tumors from Cx43 Het mice
compared to those from WT mice (Fig. 6a, top panel).
Quantification of the average area of CD31+ endothelial
cells confirmed a significant 47.7 % increase in area of
CD31+ cells (Fig. 6b lower panel, p = 0.023) in Cx43 Het
mice compared to WT mice. The presence of NG2+ peri-
cytes on these vessels (Fig. 6b, top panel) was significantly
decreased over two-fold in the Cx43 Het mice comparedto WT mice (Fig. 6b, lower panel, p < 0.005), suggesting
decreased vessel stabilization. Despite the observed in-
crease in vascularity, no change in the growth rate over
time (Fig. 6c) or final tumor mass (Fig. 6d) was observed
in tumors from Cx43 Het mice compared to WT.
Discussion
The ability of pericytes to prevent endothelial prolifera-
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Fig. 5 Breast tumor cells inhibit GJ activity and release endothelial
cells from mural cell-induced growth inhibition in a Cx43-dependent
manner. a. vSMC nucleofected with control vector or vector
overexpressing wild-type Cx43 were treated with control media
(‘Mock’) or MDA-MB-231 conditioned media (‘231 CM’), loaded with
calcein-AM, and plated onto HUVEC labeled with PHK26. Dye transfer
from vSMC to HUVEC was quantified using flow cytometry (*p< 0.05; ns,
not significant). Data represent the mean+/− s.e.m. of three experiments
performed in triplicate. b. vSMC nucleofected with control vector or
vector overexpressing wild-type Cx43 were plated with GFP-HUVEC
in the presence of control media or media conditioned for 24 h by
231 cells. Fluorescence was analyzed after four days as in Fig. 1.
Data represent the mean+/−s.e.m. of four experiments with two
vSMC donors performed in triplicate or duplicate.(*p < 0.05; **p < 0.01;
ns, not significant). c. Western analysis of vSMC nucleofected with
control vector or Cx43 overexpression vector and exposed to MDA-
MB-231 conditioned media for 24 h
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[24], diabetic retinopathy [25], and cancer [4, 5] are char-
acterized by decreased pericyte association with endothe-
lium. The importance of the initial dissociation step intumor angiogenesis is underscored by the ability of breast
cancer cells to increase initiation of angiogenesis without
increasing neovessel growth rate [26]. Here we have used
an in vitro model system to examine the ability of tumors
to free endothelial cells from mural cell-induced quies-
cence in order to mimic this initiation. Mechanistically,
we have determined that aggressive tumors may target
mural cell Cx43 to prevent or disrupt these functional
inhibitory associations to allow for a proliferative and
angiogenic endothelium. Our data further indicate a
previously unappreciated requirement for mural cell
Cx43 expression and gap junction activity in mediating
the functional interactions required for maintenance of
endothelium in a quiescent state. Since enforced mural
cell coverage may decrease angiogenesis [27, 28] and en-
hance drug delivery [29], strategies to prevent mural Cx43
loss may prove therapeutically beneficial.
Although Cx43 was previously shown to be required
for the contact-dependent endothelial cell-induced differen-
tiation of mural cell precursors into functional mural cells
[9], our data extend these findings to demonstrate that con-
tinued presence of these junctions in already differentiated
mural cells is required for maintenance of endothelial qui-
escence. While several growth factor families including
PDGF, Angiopoietin-1, sphingosine-1-phosphate, and TGF-
β have been implicated in the recruitment of mural cells
during the ‘termination phase’ of normal angiogenesis
(reviewed in [30]), the mechanisms by which tumors pre-
clude functional inhibitory interactions between mural cells
and endothelial cells have remained ill-defined. Our data
suggest that downregulation of mural cell Cx43 by tumors
may represent a pivotal point in the initiation of angiogen-
esis, and/or the ability of tumors to impede the tight func-
tional mural cell-endothelial cell interactions which would
render a newly formed vessel mature and quiescent. While
the ability to downregulate mural cell Cx43 is restricted to
highly aggressive MDA-MB-231 and MDA-MB-468 cell
lines in our study, we cannot preclude the possibility that
other tumor cells may functionally inactivate Cx43 gap
junctions by other means such as phosphorylation or al-
tered Cx43 localization, which can be regulated by differ-
ent mechanisms. Indeed, it has been demonstrated that
breast tumor cells such as MCF7 can recruit mural cells
away from vessels ex vivo [31], and inactivating phosphor-
ylation of Cx43 on tumor capillaries has been reported
[32]. These data are consistent with the possibility that
tumor-induced loss of Cx43 gap junction function may di-
minish the ability of mural cells to associate appropriately
with the underlying endothelium, even when they are
physically present in the microenvironment.
A connection between Cx43/gap junction decrease and
pericyte dissociation has been suggested in other angio-
genic pathologies such as diabetic retinopathy, a condition
































































































Fig. 6 Cx43 deficiency results in enhanced angiogenesis and
decreased stabilization but does not affect tumor growth. Eo771 cells
were implanted into the mammary fat pad of female mice that were
wild-type (‘WT’) or heterozygous (‘Cx43’) for Cx43. a. Representative
tumor sections stained for CD31 (red) shown at 20x. Bottom panel
represents quantification of average CD31+ area per field (n = 8
tumors/group). *p < 0.05. b. Representative tumor sections stained
for NG2 (green) and CD31 (red). Bottom panel represents quantification
of relative area of NG2 positivity of CD31 positive vessels (5 fields/
tumor, n= 3 tumors per group); **p< 0.01. c. Tumors were measured
using calipers and volume estimated using the formula (((L +W)/2)^3)/2.
d. Tumor mass was determined at the time of sacrifice (n= 10-11)
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downregulate Cx43 on mural cells [33] and downregu-
late Cx43 on endothelial cells [34] in vitro. Consistent
with these findings, a decrease in GJ-mediated dye transfer
between retinal pericytes and endothelial cells [35] and a
decrease in Cx43 protein in retinal lysates [25] is observed
in hyperglycemic rodent models of diabetes. Of note, glo-
bal Cx43 heterozygous mice exhibit retinal pericyte loss
similar to that observed in the diabetic model [25], al-
though a mechanistic link between Cx43/GJIC and lack of
proper pericyte association on tumor vasculature has not
previously been reported. Similarly, conditions such as
ischemia or hypoxia cause pericyte dissociation from brain
microvessels in vivo [36, 37], and uncouples GJIC in
ex vivo retinal microvessels [38]. Furthermore, endothelial-
specific loss of the TGF-β signaling mediator Smad4 results
in vascular defects including impaired association between
endothelial cells and pericytes and loss of endothelial
Cx43 [39]. Together with our findings, these data from
pathologic and genetic models are consistent with a
model in which Cx43 loss in one or both vascular cell
compartments results in functional pericyte dissociation
from endothelium as a consequence of loss of heterocel-
lular GJ communication.
Previous studies have demonstrated that expression
of mural Cx43 is required for the endothelial cell-
induced differentiation of mural cell precursors into
functional, mature mural cells [9]. Since we find that
tumors downregulate mural cell Cx43, our data may
therefore suggest an explanation for the decreased ex-
pression of mature differentiation markers in tumor
vessel-associated pericytes [4]. An alternative explan-
ation for decreased mural cell stabilization of tumor
vessels is that decreased Cx43 in mural precursors may
impair their ability to migrate, as Cx43 is required for
the adhesion and motility of several cell types [40].
Additional studies will be required to confirm whether
the tumor-induced loss of Cx43 in mural cells contrib-
utes to other aspects of vessel defects that are observed
in tumors. Interestingly, it has recently been proposed
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could result in the arterio-venous shunting defect that
is commonly found in tumor vasculature [41]. To our
knowledge, our data provide the first empirical evi-
dence that tumors can functionally disrupt vascular GJ
activity in support of this hypothesis.
To confirm a requirement for Cx43 in maintaining ves-
sel quiescence in vivo, we analyzed tumor angiogenesis in
Cx43 heterozygous mice with reduced Cx43 levels. In this
experiment, we observed an increase in vascularity as
assessed by CD31+ endothelial cells in hosts with reduced
Cx43 (Fig. 6a, b). Surprisingly, the observed increase in
vascularity in the Cx43 Het mice was not associated with
an overall increase in tumor size or growth rate of the
Eo771 implanted tumors. It is unclear why tumor growth
rate in this model is not increased despite increased vascu-
larity, but possible reasons include that angiogenesis in a
wild-type host is not rate-limiting for the highly aggressive
Eo771 tumor, or that the excess vessels generated in
Cx43-deficient animals may be inefficient or not well-
perfused and therefore not provide a proliferative ad-
vantage for the tumor. Regardless of the explanation,
the increased angiogenesis in Cx43-deficient animals is
consistent with our in vitro observations that mural
cells lacking sufficient Cx43 cannot exert growth inhibi-
tory influence on endothelial cells. Because we used a
global Cx43 heterozygote as host, however, we cannot
preclude the possibility that Cx43 loss in endothelial
cells or host cells other than mural cells may cause or
allow increased endothelial proliferation. In contrast with
this possibility, previous work suggests that Cx43 hetero-
zygosity is associated with apoptosis of retinal endothelial
cells [25], and knockdown of Cx43 in endothelial cells
[42] or endothelial progenitor cells impairs proliferation
[43]. To better define the role of mural cell Cx43 in
tumor vessels, we generated smooth muscle-specific
Cx43 knockout mice to use as a tumor host for syngen-
eic tumor cells. However, we found that a cross between
SM-22α-KI mice [44] with Cx43-floxed mice [15] re-
sults in neonatal lethality of homozygotes (postnatal day
8–12, unpublished observation). The phenotype of these
mice is currently being characterized.Conclusions
Our studies identify a novel role for mural cell Cx43 in
maintaining quiescence and stability of the vasculature,
and suggest that targeting of this molecule by tumors
may play a role in the diminished functional mural cell-
endothelial association in tumors that allows tumor
endothelium to become and remain proliferative. Mural
cell Cx43 and vascular GJ communication may therefore
prove to be attractive targets to prevent tumor angiogen-
esis and/or facilitate vessel normalization.Additional files
Additional file 1: Figure S1. Conditioned media from MDA-MB-231
cells does not negatively impact SMC proliferation. vSMC plated in
monoculture were subjected to MTS assay four days post-plating. (n = 3
experiments performed in triplicate; p < 0.05).
Additional file 2: Figure S2. GAP26 Peptide does not inhibit endothelial
proliferation. GFP-HUVEC monocultures were treated for four days in the
presence of GAP26 blocking peptide or control scrambled peptide (Scr),
then proliferation assessed by cell counting followed by flow cytometry.
Data represent mean of three experiments performed in duplicate or
triplicate.
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